GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA en liquidation (OTCPK:ELVYY) » Definitions » 5-Year ROIIC %

Evolva Holding en liquidation (Evolva Holding en liquidation) 5-Year ROIIC % : 11.31% (As of Dec. 2022)


View and export this data going back to 2014. Start your Free Trial

What is Evolva Holding en liquidation 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Evolva Holding en liquidation's 5-Year ROIIC % for the quarter that ended in Dec. 2022 was 11.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Evolva Holding en liquidation's 5-Year ROIIC % or its related term are showing as below:

ELVYY's 5-Year ROIIC % is ranked better than
68.79% of 1384 companies
in the Biotechnology industry
Industry Median: -19.885 vs ELVYY: 11.31

Evolva Holding en liquidation 5-Year ROIIC % Historical Data

The historical data trend for Evolva Holding en liquidation's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding en liquidation 5-Year ROIIC % Chart

Evolva Holding en liquidation Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.62 -34.32 -309.00 55.93 11.31

Evolva Holding en liquidation Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 55.93 - 11.31 -

Competitive Comparison of Evolva Holding en liquidation's 5-Year ROIIC %

For the Biotechnology subindustry, Evolva Holding en liquidation's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding en liquidation's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's 5-Year ROIIC % falls into.



Evolva Holding en liquidation 5-Year ROIIC % Calculation

Evolva Holding en liquidation's 5-Year ROIIC % for the quarter that ended in Dec. 2022 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -43.363 (Dec. 2022) - -38.5399752 (Dec. 2017) )/( 130.573 (Dec. 2022) - 144.329 (Dec. 2017) )
=-4.8230248/-13.756
=35.06%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Evolva Holding en liquidation  (OTCPK:ELVYY) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Evolva Holding en liquidation 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding en liquidation (Evolva Holding en liquidation) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research 02-13-2024